Platelet adhesion to collagen type IV under flow conditions. 1996

G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
Department of Haematology, University Hospital Utrecht, The Netherlands.

Collagen type IV is a sheet-forming collagen and a major constituent of the vessel wall. To find out which conditions are important for platelet adhesion to collagen type IV, we performed perfusion studies with anticoagulated blood in parallel plate perfusion chambers. The role of divalent cations was investigated by using plasmas with variable concentrations of Mg2+ and Ca2+ ions. When Mg2+ concentration was decreased from 2.00 mmol/L to 0.25 mmol/L at a fixed Ca2+ concentration of 1.25 mmol/L, platelet coverage on the collagen type IV surface decreased from 22.8% +/- 1.8% (n = 4) to 4.6% +/- 0.6% (n = 4) at a shear rate of 1,600 s-1. Also, platelet aggregate formation on collagen type IV was strongly impaired. A monoclonal antibody against the glycoprotein (Gp) Ib receptor and von Willebrand factor (vWF)-depleted plasma reduced the platelet coverage to collagen type IV to, respectively, 10% and 45% of the control value. Electron microscopy showed that vWF was only present between platelets and between the platelet and the collagen type IV surface, but did not bind elsewhere to collagen type IV. These data indicate that collagen type IV is a reactive collagen for platelets. Differences in physiologic plasma magnesium concentrations may in part explain the differences in platelet reactivity to collagen type IV between individuals, and perhaps contribute to differences in the risk for thrombosis.

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D010973 Platelet Adhesiveness The process whereby PLATELETS adhere to something other than platelets, e.g., COLLAGEN; BASEMENT MEMBRANE; MICROFIBRILS; or other "foreign" surfaces. Adhesiveness, Platelet,Adhesivenesses, Platelet,Platelet Adhesivenesses
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular
D018056 Hemorheology The deformation and flow behavior of BLOOD and its elements i.e., PLASMA; ERYTHROCYTES; WHITE BLOOD CELLS; and BLOOD PLATELETS. Hemorrheology
D019038 Platelet Glycoprotein GPIb-IX Complex Platelet membrane glycoprotein complex essential for normal platelet adhesion and clot formation at sites of vascular injury. It is composed of three polypeptides, GPIb alpha, GPIb beta, and GPIX. Glycoprotein Ib functions as a receptor for von Willebrand factor and for thrombin. Congenital deficiency of the GPIb-IX complex results in Bernard-Soulier syndrome. The platelet glycoprotein GPV associates with GPIb-IX and is also absent in Bernard-Soulier syndrome. Antigens, CD42a,Antigens, CD42b,Antigens, CD42c,Antigens, CD42d,CD42a Antigens,CD42b Antigens,CD42c Antigens,CD42d Antigens,Platelet Membrane Glycoprotein IX,Platelet Membrane Glycoprotein Ib,Platelet Membrane Glycoprotein V,CD42a Antigen,CD42b Antigen,CD42c Antigen,CD42d Antigen,Glycoprotein Ib,Glycoprotein Ib alpha,Glycoprotein Ib beta,Glycoprotein Ib-IX Complex,Platelet Glycoprotein IX,Antigen, CD42a,Antigen, CD42b,Antigen, CD42c,Antigen, CD42d,Glycoprotein Ib IX Complex,Platelet Glycoprotein GPIb IX Complex

Related Publications

G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
May 1994, Thrombosis research,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
June 1994, Blood,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
April 1995, Blood,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
November 1993, Blood,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
July 2004, Annals of biomedical engineering,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
December 2014, Artificial organs,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
January 1999, Thrombosis and haemostasis,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
September 1996, Blood,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
November 1991, Diabetes,
G Henrita van Zanten, and E U Saelman, and K M Schut-Hese, and Y P Wu, and P J Slootweg, and H K Nieuwenhuis, and P G de Groot, and J J Sixma
July 1992, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!